This chapter includes answers to practice‐based questions covering the new principles of diagnosis, treatment, and outcomes in Primary Myelofibrosis (PMF).
Venugopal, Sangeetha +3 more
core +1 more source
Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates. [PDF]
Al-Zubaidi N +3 more
europepmc +1 more source
Describing the use of ruxolitinib for the treatment of myelofibrosis: a plain language summary of the ROMEI early study results. [PDF]
Breccia M +4 more
europepmc +1 more source
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis. [PDF]
Frioni F +15 more
europepmc +1 more source
Allogeneic stem cell transplantation for myelofibrosis in the modern era: Single-center outcomes with DIPSS risk stratification. [PDF]
Choi DH, Jang JH, Jung CW.
europepmc +1 more source
Exploring the Origin of Cells in the Progression of Primary Myelofibrosis to Acute Myeloid Leukemia Case Report. [PDF]
Papayanis P +4 more
europepmc +1 more source
Risk of thromboembolic events in patients with polycythaemia vera: a study based on german health claims data. [PDF]
Manz KC +7 more
europepmc +1 more source
Treosulfan-Based Conditioning in Allogeneic Stem Cell Transplantation for Myelofibrosis: A Systematic Review. [PDF]
Nasiri A +3 more
europepmc +1 more source
Mutant calreticulin-Cancer driver and Achilles' heel for ET? [PDF]
Reichert M, Psaila B.
europepmc +1 more source

